LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Bladder Cancer Screen 6 Tissue Microarray - LS-SBLCA6

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SBLCA6
Product Name: Bladder Cancer Screen 6
Description: Bladder cancer with stage/grade and normal/non-neoplastic bladder
Format: FFPE
Category: Human Tumor and Normal
QA/QC: H&E reviewed
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Core Diameter: 1.5 mm
Core Thickness: 5 µm
Cases: 80
Cores: 80
Slides Per Set: 1

LS-SBLCA6 Tissue Microarray Map

Slide Number 1
LABEL
 12345678910
ABlaBlaBlaBlaBlaBlaBlaBlaBlaBla
BBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
CBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
DBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
EBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
FBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
GBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
HBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Bladder (Bla); Bladder, Fibrous tissue and blood vessel (Bla); Bladder, Mucosa (Bla); Bladder, Smooth muscle and blood vessel (Bla);

LS-SBLCA6 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTumor Grade
1A1HumanM67 yBladder (Bla)Transitional cell carcinomaMalignant1
1A2HumanM70 yBladder (Bla)Transitional cell carcinomaMalignant1-2
1A3HumanF56 yBladder (Bla)Transitional cell carcinomaMalignant1
1A4HumanM60 yBladder (Bla)Transitional cell carcinomaMalignant1-2
1A5HumanM56 yBladder (Bla)Transitional cell carcinomaMalignant2
1A6HumanF76 yBladder (Bla)Transitional cell carcinomaMalignant2-3
1A7HumanM61 yBladder (Bla)Transitional cell carcinomaMalignant2
1A8HumanM57 yBladder (Bla)Transitional cell carcinomaMalignant2
1A9HumanM56 yBladder (Bla)Transitional cell carcinomaMalignant1
1A10HumanM66 yBladder (Bla)Transitional cell carcinomaMalignant2
1B1HumanF45 yBladder (Bla)Transitional cell carcinomaMalignant2
1B2HumanM43 yBladder (Bla)Transitional cell carcinomaMalignant2
1B3HumanF79 yBladder (Bla)Transitional cell carcinomaMalignant2
1B4HumanM65 yBladder (Bla)Transitional cell carcinomaMalignant2
1B5HumanM57 yBladder (Bla)Transitional cell carcinomaMalignant3
1B6HumanM82 yBladder (Bla)Transitional cell carcinomaMalignant2
1B7HumanF37 yBladder (Bla)Transitional cell carcinomaMalignant3
1B8HumanM72 yBladder (Bla)Transitional cell carcinomaMalignant3
1B9HumanM45 yBladder (Bla)Transitional cell carcinomaMalignant1
1B10HumanM63 yBladder (Bla)Transitional cell carcinomaMalignant2
1C1HumanF54 yBladder (Bla)Transitional cell carcinomaMalignant1
1C2HumanM65 yBladder (Bla)Transitional cell carcinomaMalignant2
1C3HumanM76 yBladder (Bla)Transitional cell carcinomaMalignant1
1C4HumanF47 yBladder (Bla)Transitional cell carcinomaMalignant2-3
1C5HumanM60 yBladder (Bla)Transitional cell carcinomaMalignant3
1C6HumanM42 yBladder (Bla)Transitional cell carcinomaMalignant2
1C7HumanM50 yBladder (Bla)Transitional cell carcinomaMalignant3
1C8HumanM76 yBladder (Bla)Transitional cell carcinomaMalignant3
1C9HumanM58 yBladder (Bla)Transitional cell carcinomaMalignant3
1C10HumanM38 yBladder (Bla)Transitional cell carcinomaMalignant2
1D1HumanM62 yBladder (Bla)Transitional cell carcinomaMalignant2
1D2HumanF61 yBladder (Bla)Transitional cell carcinomaMalignant2
1D3HumanF67 yBladder (Bla)Transitional cell carcinomaMalignant3
1D4HumanM45 yBladder (Bla)Transitional cell carcinomaMalignant2
1D5HumanM88 yBladder (Bla)Transitional cell carcinomaMalignant3
1D6HumanM71 yBladder (Bla)Transitional cell carcinomaMalignant3
1D7HumanM70 yBladder (Bla)Transitional cell carcinomaMalignant1-2
1D8HumanM72 yBladder (Bla)Transitional cell carcinomaMalignant2
1D9HumanM72 yBladder (Bla)Transitional cell carcinomaMalignant2
1D10HumanM55 yBladder (Bla)Transitional cell carcinomaMalignant3
1E1HumanM66 yBladder (Bla)Transitional cell carcinomaMalignant2
1E2HumanF64 yBladder (Bla)Transitional cell carcinomaMalignant2
1E3HumanF58 yBladder (Bla)Transitional cell carcinomaMalignant2
1E4HumanM45 yBladder (Bla)Transitional cell carcinomaMalignant2
1E5HumanM69 yBladder (Bla)Transitional cell carcinomaMalignant2
1E6HumanM71 yBladder (Bla)Transitional cell carcinomaMalignant2
1E7HumanM64 yBladder (Bla)Transitional cell carcinomaMalignant3
1E8HumanF52 yBladder (Bla)Transitional cell carcinomaMalignant2
1E9HumanM80 yBladder (Bla)Transitional cell carcinomaMalignant2
1E10HumanM63 yBladder (Bla)Transitional cell carcinomaMalignant2
1F1HumanF48 yBladder (Bla)Transitional cell carcinomaMalignant2
1F2HumanM68 yBladder (Bla)Transitional cell carcinomaMalignant2-3
1F3HumanM70 yBladder (Bla)Transitional cell carcinomaMalignant3
1F4HumanM76 yBladder (Bla)Transitional cell carcinomaMalignant3
1F5HumanM69 yBladder (Bla)Transitional cell carcinomaMalignant3
1F6HumanM65 yBladder, Fibrous tissue and blood vessel (Bla)Transitional cell carcinoma with chronic inflammationMalignant 
1F7HumanF65 yBladder (Bla)Transitional cell carcinomaMalignant3
1F8HumanM69 yBladder (Bla)AdenocarcinomaMalignant2
1F9HumanM66 yBladder, Smooth muscle and blood vessel (Bla)AdenocarcinomaMalignant 
1F10HumanM67 yBladder (Bla)Transitional cell carcinomaMalignant2
1G1HumanM58 yBladder (Bla)Adjacent normalBenign non-neoplastic 
1G2HumanM72 yBladder (Bla)Adjacent normalBenign non-neoplastic 
1G3HumanF67 yBladder (Bla)Adjacent normalBenign non-neoplastic 
1G4HumanM68 yBladder, Smooth muscle and blood vessel (Bla)Adjacent normalBenign non-neoplastic 
1G5HumanF78 yBladder, Mucosa (Bla)Adjacent normal with cystitisDiseased 
1G6HumanM67 yBladder, Mucosa (Bla)Adjacent normal with cystitisDiseased 
1G7HumanM33 yBladder (Bla)Adjacent normalBenign non-neoplastic 
1G8HumanM68 yBladder (Bla)Adjacent normalBenign non-neoplastic 
1G9HumanM56 yBladder (Bla)Adjacent normalBenign non-neoplastic 
1G10HumanF58 yBladder, Fibrous tissue and blood vessel (Bla)Adjacent normalBenign non-neoplastic 
1H1HumanF18 yBladder (Bla)NormalBenign non-neoplastic 
1H2HumanF15 yBladder, Smooth muscle and blood vessel (Bla)NormalBenign non-neoplastic 
1H3HumanF21 yBladder (Bla)NormalBenign non-neoplastic 
1H4HumanF21 yBladder, Smooth muscle and blood vessel (Bla)NormalBenign non-neoplastic 
1H5HumanM35 yBladder, Smooth muscle and blood vessel (Bla)NormalBenign non-neoplastic 
1H6HumanM50 yBladder (Bla)NormalBenign non-neoplastic 
1H7HumanM22 yBladder (Bla)NormalBenign non-neoplastic 
1H8HumanM45 yBladder (Bla)NormalBenign non-neoplastic 
1H9HumanF41 yBladder (Bla)NormalBenign non-neoplastic 
1H10HumanM48 yBladder (Bla)Adjacent normalBenign non-neoplastic 
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved